1. Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial. Issue 12 (December 2019) Authors: Khalaf, Daniel J; Annala, Matti; Taavitsainen, Sinja; Finch, Daygen L; Oja, Conrad; Vergidis, Joanna; Zulfiqar, Muhammad; Sunderland, Katherine; Azad, Arun A; Kollmannsberger, Christian K; Eigl, Bernhard J; Noonan, Krista; Wadhwa, Deepa; Attwell, Andrew; Keith, Bruce; Ellard, Susan L; Le, Lyly; G... Journal: Lancet oncology Issue: Volume 20:Issue 12(2019) Page Start: 1730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗